LOXAPAC 50 mg, film-coated tablet 30 tablets, CIP 3400933435745
Active ingredients: Loxapine, Loxapine succinate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400933435745orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOXAPAC 50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- CNX THERAPEUTICS FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1996
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66002781CIP73343574CIP133400933435745Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCCINATE DE LOXAPINEcomprimé | 68 mg · un comprimé | SA |
| LOXAPINE BASEcomprimé | 50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.